Periodic Reporting for period 1 - IVORIaN (RAS/C-RAF interaction: A new pharmacological target in Kras-driven lung cancer.)

Lung cancer is the leading cause of cancer-related deaths worldwide, accounting for an estimated 2 million new cases per year in 2018 (https://www.wcrf.org/dietandcancer/cancer-trends/lung-cancer-statistics). The most frequent mutations found in patients occur in genes...